# MyOme and SickKids Collaborate to Clinically Validate DNA Methylation Signatures Using Long-Read Sequencing

- Source: PR Newswire M&A
- Published: 2026-11-04T17:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/myome-and-sickkids-collaborate-to-clinically-validate-dna-methylation-signatures-using-long-read-sequencing-302928805.html
- Canonical: https://groundlevelnews.com/story/myome-and-sickkids-collaborate-to-clinically-validate-dna-methylation--e29c88/

MyOme Licenses SickKids-Developed DNA Methylation Signatures to Strengthen Long-Read Rare Disease Testing. MENLO PARK, Calif., Nov. 4, 2026 /PRNewswire/ -- MyOme, a CLIA-certified, CAP-accredited clinical whole-genome analysis company, today announced a licensing and research agreement...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._